作为大脑神经退行症催化剂的P2Y1受体
Ricardo J Rodrigues1,2, Ana S Figueira1,2, Joana M Marques1,2
1CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.
NeuroSci
|November 1, 2024
概括
P2Y1受体 (P2Y1R) 通过促进天体细胞过活和神经元损伤,有助于各种大脑疾病的神经退行. 了解P2Y1RR的理解
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 大脑疾病共享病原性事件,包括细胞外腺三酸盐 (ATP) 水平的增加.
- purinergic受体 (P2和P1) 和ATP代谢酶与神经保护和神经退行有关.
- P2Y1受体 (P2Y1R) 是一个关键的纯能受体,在突触和天体细胞功能中起着重要的作用.
研究的目的:
- 审查P2Y1受体 (P2Y1R) 在急性和慢性神经退行性脑疾病中的参与.
- 阐明P2Y1R对神经退行产生影响的潜在机制.
主要方法:
- 关于P2Y1R在脑病理中的当前证据的文献综述.
- 分析P2Y1R的分布,功能和在天体细胞-神经元通信中的作用.
- 检查P2Y1R对天体细胞过活性的贡献,波,谷氨酸释放和神经元损伤.
主要成果:
- P2Y1R在大脑中表现出广泛分布,调节神经元和天体细胞活动.
- 有证据表明,P2Y1R在各种大脑病理中具有有害的功能增益.
- P2Y1R通过天体细胞过活,信号传递和谷氨酸释放促进神经退行,可能涉及微质细胞.
结论:
- P2Y1受体 (P2Y1R) 在各种神经退行性疾病的发病过程中发挥着重要作用.
- 准P2Y1R可能为急性和慢性脑疾病提供治疗策略.
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.1K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.1K
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
GPCR Desensitization
5.8K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.8K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
477
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
477
The Blood-brain Barrier
46.8K
Overview
46.8K
Enzyme-linked Receptors
77.4K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
77.4K


